Vehicular Particulate Matter (PM) Characteristics Impact Vascular Outcomes Following Inhalation

  • Katherine E. ZychowskiEmail author
  • Christina R. Steadman Tyler
  • Bethany Sanchez
  • Molly Harmon
  • June Liu
  • Hammad Irshad
  • Jacob D. McDonald
  • Barry E. Bleske
  • Matthew J. Campen


Roadside proximity and exposure to mixed vehicular emissions (MVE) have been linked to adverse pulmonary and vascular outcomes. However, because of the complex nature of the contribution of particulate matter (PM) versus gases, it is difficult to decipher the precise causative factors regarding PM and the copollutant gaseous fraction. To this end, C57BL/6 and apolipoprotein E knockout mice (ApoE−/−) were exposed to either filtered air (FA), fine particulate (FP), FP+gases (FP+G), ultrafine particulate (UFP), or UFP+gases (UFP+G). Two different timeframes were employed: 1-day (acute) or 30-day (subchronic) exposures. Examined biological endpoints included aortic vasoreactivity, aortic lesion quantification, and aortic mRNA expression. Impairments in vasorelaxation were observed following acute exposure to FP+G in C57BL/6 animals and FP, UFP, and UFP+G in ApoE−/− animals. These effects were completely abrogated or markedly reduced following subchronic exposure. Aortic lesion quantification in ApoE−/− animals indicated a significant increase in atheroma size in the UFP-, FP-, and FP+G-exposed groups. Additionally, ApoE−/− mice demonstrated a significant fold increase in TNFα expression following FP+G exposure and ET-1 following UFP exposure. Interestingly, C57BL/6 aortic gene expression varied widely across exposure groups. TNFα decreased significantly following FP exposure and CCL-5 decreased in the UFP-, FP-, and FP+G-exposed groups. Conversely, ET-1, CCL-2, and CXCL-1 were all significantly upregulated in the FP+G group. These findings suggest that gas–particle interactions may play a role in vascular toxicity, but the contribution of surface area is not clear.


Cardiovascular Particulate matter Pulmonary Diesel exhaust Vascular toxicity Vehicle emissions 



We thank Dr. Jesse Denson for manuscript editing and assistance in preparation.


This work has been supported by the ASERT-IRACDA program at UNM (K12GM088021) and NIEHS (K99ES029104; R01 ES014639).

Compliance with Ethical Standards

Conflicts of interest

The authors confirm that they have no conflicts of interest, financial or otherwise, with the contents of this manuscript.

Ethical Approval

Studies were conducted with full approval by the Institutional Animal Care and Use Committees of both the University of New Mexico and Lovelace Respiratory Research Institute.


  1. 1.
    Hoffmann, B., et al. (2007). Residential exposure to traffic is associated with coronary atherosclerosis. Circulation, 116(5), 489–496.CrossRefGoogle Scholar
  2. 2.
    Mills, N. L., et al. (2009). Adverse cardiovascular effects of air pollution. Nature Clinical Practice Cardiovascular Medicine, 6(1), 36–44.CrossRefGoogle Scholar
  3. 3.
    Pope, C. A., 3rd, et al. (2011). Vascular function and short-term exposure to fine particulate air pollution. Journal of the Air and Waste Management Association, 61(8), 858–863.CrossRefGoogle Scholar
  4. 4.
    Ruidavets, J. B., et al. (2005). Ozone air pollution is associated with acute myocardial infarction. Circulation, 111(5), 563–569.CrossRefGoogle Scholar
  5. 5.
    Wellenius, G. A., et al. (2012). Ambient air pollution and the risk of acute ischemic stroke. Archives of Internal Medicine, 172(3), 229–234.CrossRefGoogle Scholar
  6. 6.
    Maynard, A. D. A. E. D. K. (2005). Airborne nanostructured particles and occupational health. Journal of Nanoparticle Research, 7(6), 587–614.CrossRefGoogle Scholar
  7. 7.
    Schwarze, P. E., et al. (2006). Particulate matter properties and health effects: consistency of epidemiological and toxicological studies. Human and Experimental Toxicology, 25(10), 559–579.CrossRefGoogle Scholar
  8. 8.
    Dockery, D. W., et al. (1993). An association between air pollution and mortality in six U.S. cities. The New England Journal of Medicine, 329(24), 1753–1759.CrossRefGoogle Scholar
  9. 9.
    Vedal, S., et al. (2013). National Particle Component Toxicity (NPACT) initiative report on cardiovascular effects. Research Report/Health Effects Institute, 178, 5–8.Google Scholar
  10. 10.
    Campen, M., et al. (2014). Engine exhaust particulate and gas phase contributions to vascular toxicity. Inhalation Toxicology, 26(6), 353–360.CrossRefGoogle Scholar
  11. 11.
    Tyler, C. R., et al. (2016). Surface area-dependence of gas-particle interactions influences pulmonary and neuroinflammatory outcomes. Particle and Fibre Toxicology, 13(1), 64.CrossRefGoogle Scholar
  12. 12.
    Bai, N., et al. (2011). Changes in atherosclerotic plaques induced by inhalation of diesel exhaust. Atherosclerosis, 216(2), 299–306.CrossRefGoogle Scholar
  13. 13.
    Campen, M. J., et al. (2010). Inhaled diesel emissions alter atherosclerotic plaque composition in ApoE(−/−) mice. Toxicology and Applied Pharmacology, 242(3), 310–317.CrossRefGoogle Scholar
  14. 14.
    Hansen, C. S., et al. (2007). Diesel exhaust particles induce endothelial dysfunction in apoE−/− mice. Toxicology and Applied Pharmacology, 219(1), 24–32.CrossRefGoogle Scholar
  15. 15.
    Hazari, M. S., et al. (2011). TRPA1 and sympathetic activation contribute to increased risk of triggered cardiac arrhythmias in hypertensive rats exposed to diesel exhaust. Environmental Health Perspectives, 119(7), 951–957.CrossRefGoogle Scholar
  16. 16.
    Quan, C., et al. (2010). Comparative effects of inhaled diesel exhaust and ambient fine particles on inflammation, atherosclerosis, and vascular dysfunction. Inhalation Toxicology, 22(9), 738–753.CrossRefGoogle Scholar
  17. 17.
    Miller, M. R., et al. (2013). Diesel exhaust particulate increases the size and complexity of lesions in atherosclerotic mice. Particle and Fibre Toxicology, 10, 61.CrossRefGoogle Scholar
  18. 18.
    Araujo, J. A., et al. (2008). Ambient particulate pollutants in the ultrafine range promote early atherosclerosis and systemic oxidative stress. Circulation Research, 102(5), 589–596.CrossRefGoogle Scholar
  19. 19.
    Sun, Q., et al. (2005). Long-term air pollution exposure and acceleration of atherosclerosis and vascular inflammation in an animal model. JAMA, 294(23), 3003–3010.CrossRefGoogle Scholar
  20. 20.
    Lund, A. K., et al. (2007). Gasoline exhaust emissions induce vascular remodeling pathways involved in atherosclerosis. Toxicological Sciences, 95(2), 485–494.CrossRefGoogle Scholar
  21. 21.
    Bisig, C., et al. (2018). Assessment of lung cell toxicity of various gasoline engine exhausts using a versatile in vitro exposure system. Environmental Pollution, 235, 263–271.CrossRefGoogle Scholar
  22. 22.
    Lund, A. K., et al. (2011). The oxidized low-density lipoprotein receptor mediates vascular effects of inhaled vehicle emissions. American Journal of Respiratory and Critical Care Medicine, 184(1), 82–91.CrossRefGoogle Scholar
  23. 23.
    Lennox Siwale, L. K., Adam, T., Bereczky, A., Mbarawa, M., Penninger, A., & Kolesnikov, A. (2013). Combustion and emission characteristics of n-butanol/diesel fuel blend in a turbo-charged compression ignition engine. Fuel, 107, 409–418.CrossRefGoogle Scholar
  24. 24.
    Frank Ruiz, M. C., Lopez, A., Sanchez-Valdepenas, J., & Agudelo, J. R. (2015). Impact of dual-fuel combustion with n-butanol or hydrous ethanol on the oxidation reactivity and nanostructure of diesel particulate matter. Fuel, 161, 18–25.CrossRefGoogle Scholar
  25. 25.
    Cheung, C. S., Zhu, L., & Huang, Z. (2009). Regulated and unregulated emissions from a diesel engine fueled with biodiesel and biodiesel blended with methanol. Atmospheric Environment, 43(32), 4865–4872.CrossRefGoogle Scholar
  26. 26.
    de Brito, J. M., et al. (2018). Acute exposure to diesel and sewage biodiesel exhaust causes pulmonary and systemic inflammation in mice. Science of the Total Environment, 628–629, 1223–1233.CrossRefGoogle Scholar
  27. 27.
    Cassee, F. R., et al. (2012). The biological effects of subacute inhalation of diesel exhaust following addition of cerium oxide nanoparticles in atherosclerosis-prone mice. Environmental Research, 115, 1–10.CrossRefGoogle Scholar
  28. 28.
    Zhang, J., et al. (2013). Impacts of a nanosized ceria additive on diesel engine emissions of particulate and gaseous pollutants. Environmental Science and Technology, 47(22), 13077–13085.CrossRefGoogle Scholar
  29. 29.
    Snow, S. J., et al. (2014). Inhaled diesel emissions generated with cerium oxide nanoparticle fuel additive induce adverse pulmonary and systemic effects. Toxicological Sciences, 142(2), 403–417.CrossRefGoogle Scholar
  30. 30.
    McDonald, J. D., et al. (2004). Generation and characterization of four dilutions of diesel engine exhaust for a subchronic inhalation study. Environmental Science and Technology, 38(9), 2513–2522.CrossRefGoogle Scholar
  31. 31.
    McDonald, J. D., et al. (2008). Generation and characterization of gasoline engine exhaust inhalation exposure atmospheres. Inhalation Toxicology, 20(13), 1157–1168.CrossRefGoogle Scholar
  32. 32.
    Herring, C. L., Faiola, C. L., Massoli, P., Sueper, D., Erickson, M. H., McDonald, J. D., et al. (2015). New methodology for quantifying polycyclic aromatic hydrocarbons (PAHs) using high-resolution aerosol mass spectrometry. Aerosol Science and Technology, 49(11), 1131–1148.CrossRefGoogle Scholar
  33. 33.
    Aragon, M., et al. (2016). MMP-9-dependent serum-borne bioactivity caused by multiwalled carbon nanotube exposure induces vascular dysfunction via the CD36 Scavenger receptor. Toxicological Sciences, 150(2), 488–498.CrossRefGoogle Scholar
  34. 34.
    Aragon, M. J., et al. (2016). Inflammatory and vasoactive effects of serum following inhalation of varied complex mixtures. Cardiovascular Toxicology, 16(2), 163–171.CrossRefGoogle Scholar
  35. 35.
    Brook, R. D., et al. (2010). Particulate matter air pollution and cardiovascular disease: An update to the scientific statement from the American Heart Association. Circulation, 121(21), 2331–2378.CrossRefGoogle Scholar
  36. 36.
    Pope, C. A., 3rd. (2007). Mortality effects of longer term exposures to fine particulate air pollution: review of recent epidemiological evidence. Inhalation Toxicology, 19(Suppl 1), 33–38.CrossRefGoogle Scholar
  37. 37.
    Pope, C. A., 3rd, et al. (2004). Cardiovascular mortality and long-term exposure to particulate air pollution: epidemiological evidence of general pathophysiological pathways of disease. Circulation, 109(1), 71–77.CrossRefGoogle Scholar
  38. 38.
    Hoffmann, B., et al. (2009). Chronic residential exposure to particulate matter air pollution and systemic inflammatory markers. Environmental Health Perspectives, 117(8), 1302–1308.CrossRefGoogle Scholar
  39. 39.
    Tonne, C., et al. (2007). A case-control analysis of exposure to traffic and acute myocardial infarction. Environmental Health Perspectives, 115(1), 53–57.CrossRefGoogle Scholar
  40. 40.
    Van Hee, V. C., et al. (2009). Exposure to traffic and left ventricular mass and function: The Multi-Ethnic Study of Atherosclerosis. American Journal of Respiratory and Critical Care Medicine, 179(9), 827–834.CrossRefGoogle Scholar
  41. 41.
    Sioutas, C., Delfino, R. J., & Singh, M. (2005). Exposure assessment for atmospheric ultrafine particles (UFPs) and implications in epidemiologic research. Environmental Health Perspectives, 113(8), 947–955.CrossRefGoogle Scholar
  42. 42.
    Wichmann, H. E., et al. (2000). Daily mortality and fine and ultrafine particles in Erfurt, Germany part I: role of particle number and particle mass. Research Reports: Health Effects Institute, 2000(98), 5–86. discussion 87–94.Google Scholar
  43. 43.
    Tong, H., et al. (2010). Differential cardiopulmonary effects of size-fractionated ambient particulate matter in mice. Cardiovascular Toxicology, 10(4), 259–267.CrossRefGoogle Scholar
  44. 44.
    Channell, M. M., et al. (2012). Circulating factors induce coronary endothelial cell activation following exposure to inhaled diesel exhaust and nitrogen dioxide in humans: evidence from a novel translational in vitro model. Toxicological Sciences, 127(1), 179–186.CrossRefGoogle Scholar
  45. 45.
    Robertson, S., et al. (2013). CD36 mediates endothelial dysfunction downstream of circulating factors induced by O3 exposure. Toxicological Sciences, 134(2), 304–311.CrossRefGoogle Scholar
  46. 46.
    Mostovenko, E., et al. (2019). Nanoparticle exposure driven circulating bioactive peptidome causes systemic inflammation and vascular dysfunction. Particle and Fibre Toxicology, 16(1), 20.CrossRefGoogle Scholar
  47. 47.
    Campen, M. J., Lund, A., & Rosenfeld, M. (2012). Mechanisms linking traffic-related air pollution and atherosclerosis. Current Opinion in Pulmonary Medicine, 18(2), 155–160.CrossRefGoogle Scholar
  48. 48.
    Cherng, T. W., et al. (2009). Impairment of coronary endothelial cell ET(B) receptor function after short-term inhalation exposure to whole diesel emissions. American Journal of Physiology: Regulatory, Integrative and Comparative Physiology, 297(3), R640–R647.Google Scholar
  49. 49.
    Kodavanti, U. P., et al. (2011). Vascular and cardiac impairments in rats inhaling ozone and diesel exhaust particles. Environmental Health Perspectives, 119(3), 312–318.CrossRefGoogle Scholar
  50. 50.
    Plump, A. S., et al. (1992). Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells. Cell, 71(2), 343–353.CrossRefGoogle Scholar
  51. 51.
    Zhang, S. H., et al. (1992). Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E. Science, 258(5081), 468–471.CrossRefGoogle Scholar
  52. 52.
    Rao, X., et al. (2014). CD36-dependent 7-ketocholesterol accumulation in macrophages mediates progression of atherosclerosis in response to chronic air pollution exposure. Circulation Research, 115(9), 770–780.CrossRefGoogle Scholar
  53. 53.
    Oberdorster, G. (2001). Pulmonary effects of inhaled ultrafine particles. International Archives of Occupational and Environmental Health, 74(1), 1–8.CrossRefGoogle Scholar
  54. 54.
    Sarnat, J. A., et al. (2008). Fine particle sources and cardiorespiratory morbidity: An application of chemical mass balance and factor analytical source-apportionment methods. Environmental Health Perspectives, 116(4), 459–466.CrossRefGoogle Scholar
  55. 55.
    Lund, A. K., et al. (2009). Vehicular emissions induce vascular MMP-9 expression and activity associated with endothelin-1-mediated pathways. Arteriosclerosis, Thrombosis, and Vascular Biology, 29(4), 511–517.CrossRefGoogle Scholar
  56. 56.
    Lund, A. K., et al. (2013). The effects of alpha-pinene versus toluene-derived secondary organic aerosol exposure on the expression of markers associated with vascular disease. Inhalation Toxicology, 25(6), 309–324.CrossRefGoogle Scholar
  57. 57.
    Kobayashi, T., et al. (2000). Corresponding distributions of increased endothelin-B receptor expression and increased endothelin-1 expression in the aorta of apolipoprotein E-deficient mice with advanced atherosclerosis. Pathology International, 50(12), 929–936.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2019

Authors and Affiliations

  • Katherine E. Zychowski
    • 1
    Email author
  • Christina R. Steadman Tyler
    • 2
  • Bethany Sanchez
    • 1
  • Molly Harmon
    • 1
  • June Liu
    • 3
  • Hammad Irshad
    • 3
  • Jacob D. McDonald
    • 3
  • Barry E. Bleske
    • 4
  • Matthew J. Campen
    • 1
  1. 1.Department of Pharmaceutical SciencesThe University of New Mexico, College of PharmacyAlbuquerqueUSA
  2. 2.Biosciences DivisionLos Alamos National LaboratoriesLos AlamosUSA
  3. 3.Lovelace Respiratory Research InstituteAlbuquerqueUSA
  4. 4.Department of Pharmacy Practice & Administrative SciencesThe University of New Mexico, College of PharmacyAlbuquerqueUSA

Personalised recommendations